Back to results
US 2008/0188541 A1Published application
In vivo assessment of toxicity and pharmacokinetics of methylglyoxal
OwnerManju Rayinventor
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition and treatment method to reduce the proliferation of cancerous or tumor cells, in which the combined active agents are methylglyoxal, ascorbic acid, creatine and melatonin.
Claims12
A composition for the treatment of cancer, comprising:
- methylglyoxal, ascorbic acid, creatine and melatonin.
A method of treating cancer using methylglyoxal plus ascorbic acid plus creatine plus melatonin to inhibit cell proliferation upon administration.
Dependencies are inferred from the claim text.